Thanks. Was just curious as there are so many variable and moving parts in a partner deal. For instance, Afrezza just got $150M upfront from Sanofi, plus close to $750M in milestone payments and 65%/35% profit split. The upfront payment can vary a lot depending on the terms. However, I think AMBS will try to get a higher upfront payment to fund MANF.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links